KPV

KPV is a synthetic tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of α-melanocyte-stimulating hormone (α-MSH). Supplied as a lyophilized powder, it is intended for in-vitro laboratory research into inflammatory and immunomodulatory signaling.

Molecular Profile

• CAS Number67727-97-3
• Molecular Weight342.4 g/mol
• Molecular FormulaC₁₆H₃₀N₄O₄
• SequenceLys-Pro-Val (tripeptide)
• Purity≥99.5% (HPLC-MS/MS)
• FormatLyophilized white powder
• Storage−20°C, desiccated
• ReconstitutionSterile bacteriostatic water

Research Context

KPV is studied in the preclinical literature as the C-terminal tripeptide of α-MSH, investigated in models of inflammatory signaling and epithelial biology.

Quality Assurance

Every lot is independently tested for identity and purity by SideChain Analytics (HPLC-MS/MS), and a Certificate of Analysis is available for each batch. Produced and shipped from within Canada.

Available exclusively for in-vitro laboratory research. Not a drug, natural health product, or food; not for human or veterinary use, and not evaluated for diagnostic or therapeutic application. Researchers are responsible for compliance with all applicable regulations.

• CompoundKPV
• Strength10 mg per vial
• Pack sizes1 vial · 3 pack · 6 pack
• AppearanceLyophilized white powder
• Storage−20°C, protect from light
• VerificationThird-party HPLC-MS/MS (SideChain Analytics)
• OriginNorth American made · ships from Canada

Reported in preclinical, in-vitro literature in the following research areas:

• Inflammatory-signaling models
• Epithelial & mucosal research
• Melanocortin-pathway studies
• Peptide-fragment pharmacology

These are areas of laboratory investigation only. No physiological, clinical, or health outcome is claimed or implied for any use of this compound.

KPV, the C-terminal tripeptide of α-MSH, has been reported in preclinical research to modulate inflammatory signaling pathways, including NF-κB-associated activity, in laboratory models.